2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
FDA Comment Number : EC313
Submitter : Mr. Rand Davis Date & Time: 12/09/2005 10:12:44
Organization : Mr. Rand Davis
Category : Individual Consumer
Issue Areas/Comments
GENERAL
GENERAL
I believe that there should be much more scrutiny on drugs purporting to
handle 'illnesses' that have not been determined to be physiologically
based. It is a highly charged area and highly irresponsible to allow such
drugs to be marketed the way standard products are marketed due to the proven
questionable side effects and unproven workablility of such drugs. Let the health practitioners decide based on sound, independent, 3rd party evidence. To do otherwise would be a disservice to the American public an our collective future. Thank you for your attention, Rand Davis